Country: United States
Language: English
Source: NLM (National Library of Medicine)
DOXYCYCLINE (UNII: N12000U13O) (DOXYCYCLINE ANHYDROUS - UNII:334895S862)
CIPLA USA, Inc
DOXYCYCLINE
DOXYCYCLINE ANHYDROUS 25 mg in 5 mL
ORAL
PRESCRIPTION DRUG
To reduce the development of drug-resistant bacteria and maintain effectiveness of Doxycycline for Oral Suspension, USP and other antibacterial drugs should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Doxycycline is indicated for the treatment of the following infections: - Rocky Mountain spotted fever, typhus fever and the typhus group, Q fever, rickettsialpox, and tick fevers caused by Rickettsiae. - Respiratory tract infections caused by Mycoplasma pneumoniae. - Lymphogranuloma venereum caused by Chlamydia trachomatis . - Psittacosis (ornithosis) caused by Chlamydophila psittaci . - Trachoma caused by Chlamydia trachomatis , although the infectious agent is not always elimin
Doxycycline for Oral Suspension USP is available as a raspberry-flavored, pink dry powder for oral suspension. When reconstituted, each teaspoonful (5 mL) contains doxycycline monohydrate equivalent to 25 mg of doxycycline in a 2 oz (60 mL) bottle. Dispense in a tight, light-resistant container as defined in the USP. Use child-resistant closure (as required). NDC 69097-228-43 60 mL bottle Store dry powder at 20° to 25° C (68° to 77° F). [See USP Controlled Room Temperature].
Abbreviated New Drug Application
DOXYCYCLINE- DOXYCYCLINE POWDER, FOR SUSPENSION CIPLA USA, INC ---------- DOXYCYCLINE FOR ORAL SUSPENSION, USP To reduce the development of drug-resistant bacteria and maintain the effectiveness of Doxycycline and other antibacterial drugs, Doxycycline should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. DESCRIPTION Doxycycline is an antibacterial drug synthetically derived from oxytetracycline, and is available as Doxycycline for Oral Suspension, USP (doxycycline monohydrate); for oral administration. The structural formula of doxycycline monohydrate is with a molecular formula of C H N O ·H2O and a molecular weight of 462.46. The chemical designation for doxycycline is 4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro- 3,5,10,12,12apentahydroxy-6- methyl-1,11-dioxo-2-naphthacenecarboxamide monohydrate. Doxycycline is a light-yellow crystalline powder. The molecular formula for DOXYCYCLINE HYDROCHLORIDE HEMIETHANOLATE HEMIHYDRATE (C H N O ·HCl) ·C H O·H O and the molecular weight is 1025.89. Doxycycline is a light yellow crystalline powder. Doxycycline hyclate is soluble in water, while doxycycline monohydrate is very slightly soluble in water. Doxycycline has a high degree of lipoid solubility and a low affinity for calcium binding. It is highly stable in normal human serum. Doxycycline will not degrade into an epianhydro form. Doxycycline for Oral Suspension, USP contains the following inactive ingredients: confectioner's sugar, D&C red #27 aluminum lake, ethyl acetate, maltodextrin, methylparaben, microcrystalline cellulose/ sodium carboxymethylcellulose, modified cornstarch, natural flavoring; propylparaben, simethicone and sucrose. CLINICAL PHARMACOLOGY Tetracyclines are readily absorbed and are bound to plasma proteins in varying degree. They are concentrated by the liver in the bile, and excreted in the urine and feces at high concentrations and in a biologically active form. Doxycycline is virtually completely absorbed after oral administra Read the complete document